Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-025236

Chief Accounting Officer acquired 10,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-01 Grant or award : show line 1 in the form +10,500 93,578 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +19,500 19,500 D
Loading xslF345X03/doc4.xml…